These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 25054138)
1. Investigation of estrogen receptor (ESR1) for breast cancer from traditional Chinese medicine. Hung TC; Lee WY; Chen KB; Chan YC; Chen CY Biomed Res Int; 2014; 2014():321486. PubMed ID: 25054138 [TBL] [Abstract][Full Text] [Related]
2. An investigation of small GTPases in relation to liver tumorigenesis using traditional Chinese medicine. Hung TC; Lee WY; Chen KB; Chan YC; Chen CY Biomed Res Int; 2014; 2014():428210. PubMed ID: 25045674 [TBL] [Abstract][Full Text] [Related]
3. Discovery of novel natural compound inhibitors targeting estrogen receptor α by an integrated virtual screening strategy. Yu E; Xu Y; Shi Y; Yu Q; Liu J; Xu L J Mol Model; 2019 Aug; 25(9):278. PubMed ID: 31463793 [TBL] [Abstract][Full Text] [Related]
4. Insight into HIV of IFN-induced myxovirus resistance 2 (MX2) expressed by traditional Chinese medicine. Hung TC; Lee WY; Chen KB; Chan YC; Chen CY Biomed Res Int; 2014; 2014():871576. PubMed ID: 25045710 [TBL] [Abstract][Full Text] [Related]
5. In silico investigation of potential pyruvate kinase M2 regulators from traditional Chinese medicine against cancers. Chen KC; Chen KB; Chen HY; Chen CY Biomed Res Int; 2014; 2014():189495. PubMed ID: 25089263 [TBL] [Abstract][Full Text] [Related]
6. Protein druggability assessment for natural products using in silico simulation: A case study with estrogen receptor and the flavonoid genistein. Ohbuchi K; Hirokawa T Gene; 2021 Jul; 791():145726. PubMed ID: 34010704 [TBL] [Abstract][Full Text] [Related]
7. Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation. Zhang Z; Liu J; Liu Y; Shi D; He Y; Zhao P J Ethnopharmacol; 2021 Apr; 269():113696. PubMed ID: 33358854 [TBL] [Abstract][Full Text] [Related]
8. Lead screening for CXCR4 of the human HIV infection receptor inhibited by traditional Chinese medicine. Hung TC; Lee WY; Chen KB; Chen CY Biomed Res Int; 2014; 2014():809816. PubMed ID: 24999477 [TBL] [Abstract][Full Text] [Related]
9. In silico investigation of potential mTOR inhibitors from traditional Chinese medicine for treatment of Leigh syndrome. Chen KC; Lee WY; Chen HY; Chen CY Biomed Res Int; 2014; 2014():139492. PubMed ID: 25045657 [TBL] [Abstract][Full Text] [Related]
10. In silico investigation of potential TRAF6 inhibitor from traditional Chinese medicine against cancers. Chen KC; Lee WY; Chen HY; Chen CY Biomed Res Int; 2014; 2014():429486. PubMed ID: 25089269 [TBL] [Abstract][Full Text] [Related]
11. Unveiling the ESR1 Conformational Stability and Screening Potent Inhibitors for Breast Cancer Treatment. Sharma K; Panwar U; Madhavi M; Joshi I; Chopra I; Soni L; Khan A; Bhrdwaj A; Parihar AS; Mohan VP; Prajapati L; Sharma R; Agrawal S; Hussain T; Nayarisseri A; Singh SK Med Chem; 2024; 20(3):352-368. PubMed ID: 37929724 [TBL] [Abstract][Full Text] [Related]
12. Computational design of apolipoprotein E4 inhibitors for Alzheimer's disease therapy from traditional Chinese medicine. Huang HJ; Chen HY; Lee CC; Chen CY Biomed Res Int; 2014; 2014():452625. PubMed ID: 24967370 [TBL] [Abstract][Full Text] [Related]
13. Post-docking optimization and analysis of protein-ligand interactions of estrogen receptor alpha using AMMOS software. Pencheva T; Jereva D; Miteva MA; Pajeva I Curr Comput Aided Drug Des; 2013 Mar; 9(1):83-94. PubMed ID: 23106778 [TBL] [Abstract][Full Text] [Related]
14. Lead screening for HIV-1 integrase (IN) inhibited by traditional Chinese medicine. Hung TC; Lee WY; Chen KB; Chan YC; Chen CY Biomed Res Int; 2014; 2014():479367. PubMed ID: 25013783 [TBL] [Abstract][Full Text] [Related]
15. In Silico docking studies of selected flavonoids--natural healing agents against breast cancer. Suganya J; Radha M; Naorem DL; Nishandhini M Asian Pac J Cancer Prev; 2014; 15(19):8155-9. PubMed ID: 25338999 [TBL] [Abstract][Full Text] [Related]
16. Structural insight into the antagonistic action of diarylheptanoid on human estrogen receptor alpha. Geetha Rani Y; Lakshmi BS J Biomol Struct Dyn; 2019 Mar; 37(5):1189-1203. PubMed ID: 29557271 [TBL] [Abstract][Full Text] [Related]
17. Computational prediction for designing novel ketonic derivatives as potential inhibitors for breast cancer: A trade-off between drug likeness and inhibition potency. Muhammad S; Zahir N; Bibi S; Alshahrani MY; Shafiq-urRehman ; Chaudhry AR; Sarwar F; Tousif MI Comput Biol Chem; 2024 Apr; 109():108020. PubMed ID: 38286082 [TBL] [Abstract][Full Text] [Related]
18. In silico Molecular Modelling of Selected Natural Ligands and their Binding Features with Estrogen Receptor Alpha. Maruthanila VL; Elancheran R; Roy NK; Bhattacharya A; Kunnumakkara AB; Kabilan S; Kotoky J Curr Comput Aided Drug Des; 2019; 15(1):89-96. PubMed ID: 30306879 [TBL] [Abstract][Full Text] [Related]
19. Artonin E and Structural Analogs from Artocarpus Species Abrogates Estrogen Receptor Signaling in Breast Cancer. Etti I; Abdullah R; Hashim NM; Kadir A; Abdul AB; Etti C; Malami I; Waziri P; How CW Molecules; 2016 Jun; 21(7):. PubMed ID: 27367662 [TBL] [Abstract][Full Text] [Related]
20. Uroporphyrinogen decarboxylase as a potential target for specific components of traditional Chinese medicine: a virtual screening and molecular dynamics study. Tsou YA; Chen KC; Lin HC; Chang SS; Chen CY PLoS One; 2012; 7(11):e50087. PubMed ID: 23209648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]